OBS Medical is the global leader in the development and provision of predictive algorithms for identifying critical instability in patients that is not picked up by traditional methods. Visensia® - The Safety Index™ puts leading edge technology in the hands of clinicians to help reduce the number of unexpected and avoidable deaths through simplification, risk identification and prevention.
The Visensia® algorithm improves clinical safety by examining the correlation between a patient’s physiological vital signs and provides advanced early warning of critical instability by addressing some of the emerging issues with existing early warning scoring systems. Visensia® The Safety Index™ has been designed for the Inpatient Acute Hospital setting and has been clinically validated to provide benefits to patients, caregivers and payers helping to meet today’s healthcare challenges.
Visensia® has been specifically designed and clinically proven to help with the challenges frequently met in today’s healthcare environment. These include deteriorating patients, pressures to speed the patient journey through the hospital and availability of skilled nursing staff.
Visensia’s® predictive capability can play a role in all stages of the healthcare continuum. Ranging from the pre-hospital environment for the Emergency Services and Emergency Departments (A&E), through to ICU, HDU and Medical/Surgical wards and finally remotely in the patient’s home. Visensia® helps caregivers to evaluate critical instability and provide simplification, risk identification and prevention - meeting today’s healthcare challenges.
OBS Medical are pleased to announce the publication of the Medtech Innovation Briefing (MIB) by the National Institute for Health and Care Excellence (NICE) on Visensia® – The Safety Index for the early detection of deteriorating vital signs in adults in hospital.